18th Annual School of Breast Oncology®

18th Annual School of Breast Oncology® is organized by Physicians' Education Resource, LLC (PER) and will be held from Nov 05 - 07, 2020.

Accreditation:
Physicians (CME)
Physicians' Education Resource®, LLC designates this live activity for a maximum of 27.25 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (Contact Hours)
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 27.25 Contact Hours.

Maintenance of Certification (MOC) Points
Medical Oncologists (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 27.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Program Overview:
An increasing number of oncologists are focusing their clinical practices on the treatment of breast cancer, creating a need for specialized education. The School of Breast Oncology®, which has been held annually since 2003, was developed to advance patient care by providing a curriculum-based program focused exclusively on breast cancer clinical management. This intensive 3-day interactive program will provide a comprehensive review of data on the most important aspects of breast cancer biology, diagnostics, prevention and treatment, with lectures emphasizing clinical implications presented by leading clinical investigators.

Learning Objectives:
• Review breast cancer biology, staging, and prognostic and/or predictive markers, in order to better individualize therapy and counsel patients regarding conventional and investigational treatment options
• Integrate biomarkers, molecular assays, and other risk assessment tools into treatment decision-making algorithms to optimize outcomes for patients with breast cancer
• Discuss current and evolving imaging options for diagnosing, staging, and monitoring breast cancer
• Incorporate current guidelines and evolving evidence on local treatment options, including new approaches in surgery and radiation therapy, into the management of patients with breast cancer
• Individualize selection of systemic therapies for patients with early-stage or advanced/metastatic breast cancer by taking into consideration efficacy and safety, as well as patient characteristics and tumor subtype
• Evaluate emerging clinical data and evolving strategies for the treatment of breast cancer, and apply clinical trial data appropriately in order to optimize the outcome of individual patients
• Utilize supportive care strategies for preventing and managing treatment-related toxicities in patients receiving treatment for breast cancer
• Facilitate awareness of clinical trial opportunities based on knowledge of emerging agents and variances in care in the field of breast cancer management